Trademark: 88751692
Status Date
Friday, January 20, 2023
Filing Date
Wednesday, January 8, 2020
Published for Opposition
Tuesday, March 17, 2020
Abandoned Date
Thursday, January 19, 2023
5 Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Jan 20, 2023
Abandonment Notice E-Mailed - After Publication
Jan 20, 2023
Abandonment - After Publication
Jan 19, 2023
Teas Express Abandonment Received
Nov 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 4, 2022
Sou Extension 5 Granted
Oct 26, 2022
Sou Extension 5 Filed
Nov 4, 2022
Case Assigned To Intent To Use Paralegal
Oct 26, 2022
Sou Teas Extension Received
Apr 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 25, 2022
Sou Extension 4 Granted
Apr 25, 2022
Sou Extension 4 Filed
Apr 25, 2022
Sou Teas Extension Received
Nov 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 10, 2021
Sou Extension 3 Granted
Nov 10, 2021
Sou Extension 3 Filed
Nov 10, 2021
Sou Teas Extension Received
Apr 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 15, 2021
Sou Extension 2 Granted
Apr 15, 2021
Sou Extension 2 Filed
Apr 15, 2021
Sou Teas Extension Received
Nov 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2020
Sou Extension 1 Granted
Nov 5, 2020
Sou Extension 1 Filed
Nov 5, 2020
Sou Teas Extension Received
May 12, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 17, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 17, 2020
Published For Opposition
Feb 26, 2020
Notification Of Notice Of Publication E-Mailed
Feb 7, 2020
Approved For Pub - Principal Register
Feb 6, 2020
Assigned To Examiner
Jan 13, 2020
New Application Office Supplied Data Entered
Jan 11, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
